Proceedings of 9th Annual General Meeting of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vanta Bioscience Ltd held its 9th Annual General Meeting on September 30, 2025, at 10:00 AM in Secunderabad, Telangana. The meeting was chaired by Managing Director Mr. Dopesh Raja Mulakala and attended by 9 members in person, along with key officials including the CFO, Company Secretary, and an Independent Director. Two ordinary business items were taken up: adoption of the audited standalone and consolidated financial statements for FY ended March 31, 2025, and re-appointment of Mr. Dopesh Raja Mulakala as Managing Director (retiring by rotation). Voting results and the scrutinizer's report (by CS Zoheb S Sayani) will be filed separately with BSE and CDSL in due course. The meeting concluded at 11:00 AM.
This is a routine procedural disclosure with no immediate material impact on the stock. Investors should watch for the upcoming voting results and scrutinizer's report, which will confirm shareholder approval of the financial statements and MD re-appointment. Low attendance (9 members) reflects the small-cap nature of the company.